| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4579923d27661dd10fea760553ccf784
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_83b60d3511666dbe07e2cc6edab7f9ae |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P17-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K33-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-00 |
| filingDate |
2021-03-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f7ba606c3d2b50fbb5a398fcbe31be61
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_810e36996bfe4b84a418d67cfb0b443a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e1bcd3e15c7de0fae86d428a90f0a990 |
| publicationDate |
2021-09-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
JP-2021151998-A |
| titleOfInvention |
Zinc replacement therapy after bypass surgery |
| abstract |
PROBLEM TO BE SOLVED: To provide a drug for improving the prognosis of bypass surgery. SOLUTION: A bypass operation comprising zinc acetate as an active ingredient and orally administering 50 mg of zinc twice a day after meals to a subject presenting with hypozincemia after bypass surgery. Later peripheral circulatory disorder therapeutic agent. [Selection diagram] Fig. 1 |
| priorityDate |
2020-03-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |